Original Articles
Vol. 1 No. 3 (2016)
https://doi.org/10.4081/ozone.2016.6549

The role of ozone in the treatment of the acute phase of ischemic heart disease

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 10 January 2017
Published: 18 January 2017
2698
Views
1084
Downloads
Ozone, Acute phase, Ischemic heart disease

Authors

Stefano Ciampa
Medical Surgeon, Specialist in Anesthesia, Resuscitation, Intensive Care and Pain Therapy, Italy.
Giovanni Dequerquis
Medical Surgeon, Specialist in Anesthesia, Resuscitation, Intensive Care and Pain Therapy, Italy.
Biagio Lettieri
biagio.lettieri@unina2.it
Formerly Full Professor, Department of Anesthesiologic, Surgical Emergency Sciences, Second University of Naples, Naples, Italy.
The present paper describes the role of ozone in the treatment of the acute phase of ischemic heart disease. Two studies are presented: the first mechanically induced myocardial ischemia in rats; the second involved 42 consecutive patients with an outcome comparable to the UA/non-Q wave NSTEMI AMI group of the ENACT study, divided randomly into 2 groups with homogeneous quantitative levels (NYHA class II-III) and was evaluated at weeks 8 and 12 of treatment with ozone. Both studies confirm that i) the effectiveness of ozone therapy increases in relation to how early and how long treatment is performed; and ii) that ozone reduces the relative risk both of ischemic (infarct extension) and arrhythmia complications.

Downloads

Download data is not yet available.

How to Cite



The role of ozone in the treatment of the acute phase of ischemic heart disease. (2017). Ozone Therapy, 1(3), 66-70. https://doi.org/10.4081/ozone.2016.6549

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.